G. Manukian

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma

J. Wolchok, M. Perales, A. Houghton, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Concerns for Active Breathing Control (ABC) With Breast Cancer in the Era of COVID-19: Maximizing Infection Control While Minimizing Heart Dose

N. Simone, P. Anné, Amy Taylor, 2020, Advances in Radiation Oncology.

Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.

J. Wolchok, J. Allison, A. Houghton, 2009, Cytotherapy.

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

J. Wolchok, J. Allison, N. Segal, 2008, Proceedings of the National Academy of Sciences.

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma

A. Argiris, V. Bar-ad, B. Lu, 2019, Front. Oncol..

CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.

J. Wolchok, D. Scheinberg, A. Houghton, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

CD 8 + T-Cell – Dependent Immunity Following Xenogeneic DNA Immunization against CD 20 in a Tumor Challenge Model of B-Cell Lymphoma

J. Wolchok, D. Scheinberg, A. Houghton, 2004 .

Caloric restriction impairs regulatory T-cells within the tumor microenvironment after radiation and primes effector T-cells.

N. Simone, K. Camphausen, U. Rodeck, 2021, International journal of radiation oncology, biology, physics.

Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.

J. Wolchok, A. Houghton, G. Ku, 2009, Cancer immunity.